Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective studyLiyang Hu, Qingqing Cai|Chinese Journal of Cancer|2017Cited by 56
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 studyYuqin Song, Jun Zhu, Qingqing Cai et al.|The Lancet Oncology|2023Cited by 55
BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphomaXiao‐Peng Tian, Qingqing Cai|Cancer Communications|2020Cited by 51
Targeting P21-activated kinase suppresses proliferation and enhances chemosensitivity in T-cell lymphoblastic lymphomaNing Su, Qingqing Cai|Blood Science|2023Cited by 7